• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于紫檀芪的高效α-葡萄糖苷酶抑制剂:深入研究构效关系。

Toward potent α-glucosidase inhibitors based on xanthones: a closer look into the structure-activity correlations.

机构信息

School of Chemistry & Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, PR China.

出版信息

Eur J Med Chem. 2011 Sep;46(9):4050-5. doi: 10.1016/j.ejmech.2011.06.003. Epub 2011 Jun 12.

DOI:10.1016/j.ejmech.2011.06.003
PMID:21708415
Abstract

A series of novel xanthone derivatives 6-16 having non-coplanar and flexible structures were synthesized as potent α-glucosidase inhibitors. Biological evaluation indicated that compounds 6-12 bearing one or two naphthol moieties exhibited up to 30-fold enhanced activities compared with their corresponding parent compounds 2-5, whereas compounds 13-16 bearing one dihydroxylnaphthalenyl group showed decreased activities compared with their corresponding analogs 6-9 having one naphthol group. Among them, compounds 7-8, 10-12 and 15 were more active than 1-deoxynojirimycin, a well-known inhibitor for α-glucosidase. The structure-activity correlations suggested that inhibiting of α-glucosidase was a result of multiple interactions with the enzyme, including π-stacking, hydrophobic effect and conformational flexibility due to the structural non-coplanarity. In addition, compounds 4, 8 and 15 showed non-competitive inhibition.

摘要

一系列具有非共面和柔性结构的新型黄烷酮衍生物 6-16 被合成为有效的α-葡萄糖苷酶抑制剂。生物评价表明,与相应的母体化合物 2-5 相比,带有一个或两个萘酚部分的化合物 6-12 的活性增强了高达 30 倍,而带有一个二羟基萘基部分的化合物 13-16 的活性则低于相应的带有一个萘酚部分的类似物 6-9。其中,化合物 7-8、10-12 和 15 的活性比α-葡萄糖苷酶的已知抑制剂 1-去氧野尻霉素更强。结构-活性关系表明,α-葡萄糖苷酶的抑制是与酶的多种相互作用的结果,包括π堆积、疏水性和由于结构的非共面性而导致的构象灵活性。此外,化合物 4、8 和 15 表现出非竞争性抑制。

相似文献

1
Toward potent α-glucosidase inhibitors based on xanthones: a closer look into the structure-activity correlations.基于紫檀芪的高效α-葡萄糖苷酶抑制剂:深入研究构效关系。
Eur J Med Chem. 2011 Sep;46(9):4050-5. doi: 10.1016/j.ejmech.2011.06.003. Epub 2011 Jun 12.
2
Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors.氧杂蒽酮衍生物作为α-葡萄糖苷酶抑制剂的合成及药理活性
Bioorg Med Chem. 2006 Aug 15;14(16):5683-90. doi: 10.1016/j.bmc.2006.04.014. Epub 2006 May 2.
3
Synthesis of xanthone derivatives with extended pi-systems as alpha-glucosidase inhibitors: insight into the probable binding mode.具有扩展π-体系的氧杂蒽衍生物作为α-葡萄糖苷酶抑制剂的合成:对可能结合模式的深入了解。
Bioorg Med Chem. 2007 Apr 15;15(8):2810-4. doi: 10.1016/j.bmc.2007.02.030. Epub 2007 Feb 16.
4
Binding mechanism and synergetic effects of xanthone derivatives as noncompetitive α-glucosidase inhibitors: a theoretical and experimental study.黄烷酮衍生物作为非竞争性α-葡萄糖苷酶抑制剂的结合机制和协同作用:理论与实验研究。
J Phys Chem B. 2013 Oct 31;117(43):13464-71. doi: 10.1021/jp4067235. Epub 2013 Oct 22.
5
Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.氧杂蒽酮衍生物作为α-葡萄糖苷酶抑制剂的合成、抑制活性及定量构效关系研究
Bioorg Med Chem. 2008 Aug 1;16(15):7185-92. doi: 10.1016/j.bmc.2008.06.043. Epub 2008 Jun 26.
6
Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors.羟基香豆素衍生物:新型强效α-葡萄糖苷酶抑制剂。
J Med Chem. 2010 Dec 9;53(23):8252-9. doi: 10.1021/jm100757r. Epub 2010 Nov 5.
7
Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.高野霉素异构体和N-烷基化高野霉素:糖苷酶抑制作用的结构和构象基础
J Med Chem. 1998 Jul 2;41(14):2565-71. doi: 10.1021/jm970836l.
8
alpha-Glucosidase inhibition of 6-hydroxyflavones. Part 3: Synthesis and evaluation of 2,3,4-trihydroxybenzoyl-containing flavonoid analogs and 6-aminoflavones as alpha-glucosidase inhibitors.
Bioorg Med Chem. 2005 Mar 1;13(5):1661-71. doi: 10.1016/j.bmc.2004.12.010.
9
Topological, hydrophobicity, and other descriptors on α-glucosidase inhibition: a QSAR study on xanthone derivatives.基于拓扑、疏水性和其他描述符的 α-葡萄糖苷酶抑制活性:黄烷酮衍生物的定量构效关系研究。
J Enzyme Inhib Med Chem. 2011 Dec;26(6):755-66. doi: 10.3109/14756366.2010.549089. Epub 2011 Feb 1.
10
Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents' effect.3-酰氧基氧杂蒽酮衍生物作为α-葡萄糖苷酶抑制剂的合成:对3-取代基效应的进一步深入研究。
Bioorg Med Chem. 2016 Apr 1;24(7):1431-8. doi: 10.1016/j.bmc.2016.01.022. Epub 2016 Jan 21.

引用本文的文献

1
The α-Glucosidase Inhibition Activities of Phaeochromycins D and E Isolated from Marine sp. FJ0218.从海洋菌株FJ0218中分离得到的嗜铬霉素D和E的α-葡萄糖苷酶抑制活性
Molecules. 2025 Apr 30;30(9):1993. doi: 10.3390/molecules30091993.
2
Structure-yeast α-glucosidase inhibitory activity relationship of 9-O-berberrubine carboxylates.9-O-小檗红碱羧酸酯的结构-酵母 α-葡萄糖苷酶抑制活性关系。
Sci Rep. 2023 Nov 1;13(1):18865. doi: 10.1038/s41598-023-45116-0.
3
Application of the Mannich reaction in the structural modification of natural products.
曼尼希反应在天然产物结构修饰中的应用。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2235095. doi: 10.1080/14756366.2023.2235095.
4
Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor.新型α-葡萄糖苷酶抑制剂吡唑并苯并呋喃杂合体的设计、合成、生物评价及分子模拟研究。
Sci Rep. 2021 Oct 21;11(1):20776. doi: 10.1038/s41598-021-99899-1.
5
Antioxidant and antidiabetic activities of 11 herbal plants from Hyrcania region, Iran.伊朗里海地区11种草本植物的抗氧化和抗糖尿病活性
J Food Drug Anal. 2016 Jan;24(1):179-188. doi: 10.1016/j.jfda.2015.06.010. Epub 2015 Jul 30.
6
Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.基于对接辅助的氧杂蒽酮类α-葡萄糖苷酶抑制剂的三维定量构效关系研究
J Mol Model. 2017 Aug 31;23(9):272. doi: 10.1007/s00894-017-3438-1.
7
Comparison of α-glucosidase inhibition by according to harvesting time.根据收获时间比较α-葡萄糖苷酶抑制作用。
Biomed Rep. 2013 Jul;1(4):624-628. doi: 10.3892/br.2013.111. Epub 2013 May 22.
8
Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents.1,3 - 二羟基呫吨酮曼尼希碱衍生物作为抗胆碱酯酶剂的合成与生物学评价
Chem Cent J. 2013 Apr 27;7(1):78. doi: 10.1186/1752-153X-7-78.